Wang Wen-Qiang, Lv Xing, Li Jian, Li Jiang, Wang Jin-Lin, Yuan Tong, Liu Jun-Jie, Zhu Rong-Hua, Huang Zhi-Yong, Zhang Er-Lei
Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Hepatobiliary Surgery, The First Affiliated Hospital, College of Medicine, Shihezi University, Shihezi, Xinjiang, China.
Eur J Surg Oncol. 2023 May;49(5):1001-1008. doi: 10.1016/j.ejso.2022.12.016. Epub 2022 Dec 26.
Repeat hepatectomy (RH) and microwave ablation (MWA) are frequently used procedures for the treatment of recurrent hepatocellular carcinoma (HCC) after curative resection. This study aimed to compare the long-term outcomes of RH and MWA for solitary and small HCC with early or late recurrence.
This retrospective study enrolled patients who underwent RH or MWA for solitary and small (≤3 cm) recurrent HCC at Tongji hospital between April 2006 and December 2020. Propensity score matching (PSM) was further employed to analyze the prognosis of different treatment methods.
A total of 256 patients were analyzed, of whom 94 and 162 underwent RH and MWA, respectively. The overall treatment-related complication rate was higher in the RH group. Both recurrence-free survival (RFS) and overall survival (OS) rates of RH were significantly better than those of MWA. Multivariate analysis showed that MWA, early recurrence (within 24 months after initial resection), cirrhosis, and AFP >400 ng/ml were independent risk factors for poor prognoses of recurrent HCC. The stratified analysis demonstrated that MWA and RH had similar long-term outcomes in patients with early recurrence. Nevertheless, MWA had worse RFS and OS than RH in patients with late recurrence. The same results were obtained in the PSM analysis.
The long-term outcomes of HCC patients with late recurrence were significantly better than those with early recurrence. RH should be the first choice for solitary small recurrent HCC patients with late recurrence, while MWA should be selected for those with early recurrence.
重复肝切除术(RH)和微波消融术(MWA)是治疗根治性切除术后复发性肝细胞癌(HCC)常用的手术方法。本研究旨在比较RH和MWA治疗早期或晚期复发的孤立性小肝癌的长期疗效。
本回顾性研究纳入了2006年4月至2020年12月期间在同济医院接受RH或MWA治疗孤立性小(≤3 cm)复发性HCC的患者。进一步采用倾向评分匹配(PSM)分析不同治疗方法的预后。
共分析了256例患者,其中94例和162例分别接受了RH和MWA治疗。RH组的总体治疗相关并发症发生率较高。RH组的无复发生存期(RFS)和总生存期(OS)均显著优于MWA组。多因素分析显示,MWA、早期复发(初次切除后24个月内)、肝硬化和甲胎蛋白>400 ng/ml是复发性HCC预后不良的独立危险因素。分层分析表明,早期复发患者中MWA和RH的长期疗效相似。然而,晚期复发患者中MWA的RFS和OS比RH差。PSM分析也得到了相同的结果。
晚期复发的HCC患者的长期疗效明显优于早期复发的患者。对于晚期复发的孤立性小复发性HCC患者,RH应作为首选,而对于早期复发的患者应选择MWA。